Poolbeg Pharma (POLB), a clinical-stage biopharmaceutical company targeting diseases with a high unmet medical need, announced its unaudited interim results for the six months to 30 June 2023.
Poolbeg Pharma (POLB), a clinical-stage biopharmaceutical company targeting diseases with a high unmet medical need, announced its unaudited interim results for the six months to 30 June 2023.
Pensana (PRE) advised that on 29 August 2023, 30 August 2023 and 31 August 2023, Paul Atherley purchased shares in the company.
Conroy Gold and Natural Resources (CGNR) announced assay results from six shallow drill holes (totalling c.98m) at the Company’s Creenkill gold target in its Mines Royal (Newtownhamilton) option, located in
Atlantic Lithium (ALL), the lithium exploration and development company, announced initial assay results from the resource and exploration drilling programme recently commenced at the Ewoyaa Lithium Project in Ghana, West
This post was written by Zak Mir, a Technical Analyst, Events Host, Presenter, CEO Interviewer and established Market Commentator.
This post was written by Zak Mir, a Technical Analyst, Events Host, Presenter, CEO Interviewer and established Market Commentator.
This post was written by Zak Mir, a Technical Analyst, Events Host, Presenter, CEO Interviewer and established Market Commentator.
This post was written by Zak Mir, a Technical Analyst, Events Host, Presenter, CEO Interviewer and established Market Commentator.
Avation (AVAP), the commercial passenger aircraft leasing company, announced unaudited results for the six months ended 31 December 2022. Revenue and other income reduced to $55.3 million (2021: $60.1 million).
Welcome to the weekly round-up from Share Talk, looking at the junior stock market, the AIM All-Share Index performed slightly worse than the FTSE 350, experiencing a 1.4% decline during
Shares in Conroy Gold and Natural Resources PLC (AIM: CGNR) shot up over 18% after the gold explorer announced a new discovery in the Longford-Down Massif in Ireland.